Rocket One Inc. Increase (Decrease) in Accounts Payable
Rocket One Inc. (RKTO) reported Increase (Decrease) in Accounts Payable of -$39.30 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-05-14
- Rocket One Inc. increase (decrease) in accounts payable for the quarter ending 2024-03-31 was -$39.30K.
- Rocket One Inc. increase (decrease) in accounts payable for the quarter ending 2023-12-31 was -$1.24M, a 458.74% decline year-over-year.
- Rocket One Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $207.18K, a 27.06% decline year-over-year.
- Rocket One Inc. increase (decrease) in accounts payable for the quarter ending 2023-06-30 was $378.16K, a 2571.93% increase year-over-year.
- Rocket One Inc. increase (decrease) in accounts payable for fiscal 2023 was -$700.75K, a 218.64% decline from fiscal 2022.
- Rocket One Inc. increase (decrease) in accounts payable for fiscal 2022 was $590.63K, a 10.33% increase from fiscal 2021.
- Rocket One Inc. increase (decrease) in accounts payable for fiscal 2021 was $535.34K.
- Rocket One Inc. increase (decrease) in accounts payable for fiscal 2020 was -$151.99K, a 156.85% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 8 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | -$39.30K 10-Q · filed 2024-05-14 | -$1.28M derived: sum of 2 quarters · filed 2024-05-14 | -$1.07M derived: sum of 3 quarters · filed 2024-05-14 | -$692.83K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.03M derived: sum of 2 quarters · filed 2024-03-28 | -$653.53K derived: sum of 3 quarters · filed 2024-03-28 | -$700.75K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $207.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $585.34K derived: sum of 2 quarters · filed 2023-11-13 | $538.12K 10-Q · filed 2023-11-13 | $883.45K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-06-30 | $378.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $330.93K 10-Q · filed 2023-08-11 | $676.27K derived: sum of 3 quarters · filed 2024-05-14 | $960.33K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2023-03-31 | -$47.23K 10-Q · filed 2024-05-14 | $298.11K derived: sum of 2 quarters · filed 2024-05-14 | $582.17K derived: sum of 3 quarters · filed 2024-05-14 | $596.32K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $345.34K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $629.39K derived: sum of 2 quarters · filed 2024-03-28 | $643.55K derived: sum of 3 quarters · filed 2024-03-28 | $590.63K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $284.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $298.21K derived: sum of 2 quarters · filed 2023-11-13 | $245.30K 10-Q · filed 2023-11-13 | -$500.19K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $14.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$38.76K 10-Q · filed 2023-08-11 | -$784.24K derived: sum of 3 quarters · filed 2023-08-11 | -$371.45K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$52.91K 10-Q · filed 2023-05-15 | -$798.40K derived: sum of 2 quarters · filed 2023-05-15 | -$385.60K derived: sum of 3 quarters · filed 2023-05-15 | $28.50K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$745.48K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$332.69K derived: sum of 2 quarters · filed 2023-03-31 | $81.41K derived: sum of 3 quarters · filed 2023-03-31 | $535.34K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $412.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $826.89K derived: sum of 2 quarters · filed 2022-11-10 | $1.28M 10-Q · filed 2022-11-10 | $1.38M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $414.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $868.03K 10-Q · filed 2022-08-12 | $970.31K derived: sum of 3 quarters · filed 2022-08-12 | $820.58K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $453.93K 10-Q · filed 2022-05-12 | $556.21K derived: sum of 2 quarters · filed 2022-05-12 | $406.49K derived: sum of 3 quarters · filed 2022-05-12 | $188.27K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $102.28K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$47.44K derived: sum of 2 quarters · filed 2022-03-30 | -$265.66K derived: sum of 3 quarters · filed 2022-03-30 | -$151.99K 10-K · filed 2022-03-30 | |
| 2020-09-30 | -$149.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$367.94K derived: sum of 2 quarters · filed 2021-11-10 | -$254.27K 10-Q · filed 2021-11-10 | $130.06K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$218.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$104.54K 10-Q · filed 2021-08-11 | $279.78K derived: sum of 3 quarters · filed 2021-08-11 | $97.83K derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $113.67K 10-Q · filed 2021-05-13 | $498.00K derived: sum of 2 quarters · filed 2021-05-13 | $316.05K derived: sum of 3 quarters · filed 2021-05-13 | $452.72K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $384.32K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $202.37K derived: sum of 2 quarters · filed 2021-03-16 | $339.04K derived: sum of 3 quarters · filed 2021-03-16 | $267.36K 10-K · filed 2021-03-16 | |
| 2019-09-30 | -$181.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$45.28K derived: sum of 2 quarters · filed 2020-11-10 | -$116.97K 10-Q · filed 2020-11-10 | -$388.00 derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | $136.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $64.99K 10-Q · filed 2020-08-13 | $181.56K derived: sum of 3 quarters · filed 2020-08-13 | $78.36K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$71.69K 10-Q · filed 2020-05-13 | $44.89K derived: sum of 2 quarters · filed 2020-05-13 | -$58.31K derived: sum of 3 quarters · filed 2020-05-13 | -$8.82K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $116.58K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $13.37K derived: sum of 2 quarters · filed 2020-03-02 | $62.87K derived: sum of 3 quarters · filed 2020-03-02 | $94.36K 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$103.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$53.71K derived: sum of 2 quarters · filed 2019-11-12 | -$22.22K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $49.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $80.98K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $31.48K 10-Q · filed 2019-05-15 | ||||
| 2017-12-31 | $47.92K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |